HSBC Holdings
EDIT icon

HSBC Holdings’s Editas Medicine EDIT Stock Holding History

HSBC Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Sell
97,062
-15,124
-13% -$44.2K ﹤0.01% 2496
2026
Q1 		$274K Hold
112,186
– – ﹤0.01% 2486
2025
Q4 		$231K Buy
112,186
+16,288
+17% +$47K ﹤0.01% 2636
2025
Q3 		$326K Buy
95,898
+42,870
+81% +$120K ﹤0.01% 2298
2025
Q2 		$122K Sell
53,028
-5,285
-9% -$8.65K ﹤0.01% 2808
2025
Q1 		$67.4K Sell
58,313
-63
-0.1% -$93 ﹤0.01% 2870
2024
Q4 		$72.4K Buy
58,376
+1,725
+3% +$4.39K ﹤0.01% 2944
2024
Q3 		$197K Sell
56,651
-48,143
-46% -$210K ﹤0.01% 2619
2024
Q2 		$488K Buy
104,794
+62,561
+148% +$353K ﹤0.01% 1978
2024
Q1 		$313K Buy
42,233
+10,696
+34% +$88.9K ﹤0.01% 2421
2023
Q4 		$323K Buy
31,537
+302
+1% +$2.65K ﹤0.01% 2244
2023
Q3 		$240K Buy
31,235
+18,602
+147% +$160K ﹤0.01% 2330
2023
Q2 		$104K Sell
12,633
-1,660
-12% -$14.5K ﹤0.01% 2423
2023
Q1 		$104K Buy
+14,293
New +$127K ﹤0.01% 2503
2020
Q4 		– Sell
-13,178
Closed -$374K – 3059
2020
Q3 		$374K Buy
+13,178
New +$429K ﹤0.01% 2115

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HSBC Holdings's EDIT Position: Q2 2026 in Review

HSBC Holdings reduced its Editas Medicine (EDIT) stake by 13% in Q2 2026, selling an estimated $44.2K and leaving 97,062 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

HSBC Holdings first reported a position in EDIT in Q3 2020 and has held it in 15 quarters since. The position peaked at $488K in Q2 2024. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • HSBC Holdings held 97,062 shares of Editas Medicine worth $314K as of Q2 2026.
  • HSBC Holdings sold 15,124 Editas Medicine shares in Q2 2026, an estimated $44.2K.
  • Editas Medicine made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2496 holding.
  • HSBC Holdings first reported a position in Editas Medicine in Q3 2020 and has held it in 15 quarters since.
  • HSBC Holdings's Editas Medicine position peaked at $488K in Q2 2024.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.